Pharmaceutical Drug Delivery Market Set To Grow From $2007.96 Billion In 2026 To $2612.78 Billion By 2030 At A CAGR Of 6.8%
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Pharmaceutical Drug Delivery Market Growth Potential: How Will Market Size Change Through 2030?
The pharmaceutical drug delivery market has experienced robust expansion in recent years, with projections indicating an increase from $1883.27 billion in 2025 to $2007.97 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.6%. This upward trend during the historical period is driven by several factors, including the growing frequency of chronic illnesses, progress in pharmaceutical formulation development, improvements in hospital infrastructure, a larger elderly demographic, and widespread utilization of oral and injectable delivery systems.
The pharmaceutical drug delivery market is anticipated to experience significant expansion over the coming years. By 2030, it is projected to reach a value of $2612.78 billion, driven by a compound annual growth rate (CAGR) of 6.8%. This forecasted growth is largely attributable to the rise of biologics and biosimilars, the incorporation of digital monitoring technologies, progress in nanocarrier systems, the expansion of home care and remote treatment options, and an escalating demand for therapies centered on patient needs. Key developments shaping this period encompass targeted drug delivery systems, formulations based on nanotechnology, wearable devices for drug administration, personalized medicine approaches, and techniques that are minimally invasive.
Download A Free Sample Report For Comprehensive Market Insights:
Pharmaceutical Drug Delivery Market Opportunity Drivers: What Is Creating New Revenue Potential?
The rising incidence of chronic illnesses is anticipated to drive the expansion of the pharmaceutical drug delivery market in the coming years. The term “prevalence of chronic diseases” describes the overall count of existing chronic disease cases within a specific population at a given point in time. Pharmaceutical drug delivery aids individuals suffering from these conditions by administering medication to targeted areas of the body for treating various ailments. For example, in September 2023, the World Health Organization—a specialized agency of the United Nations based in Switzerland—reported that chronic diseases, also known as non-communicable diseases (NCDs), account for 41 million deaths annually, representing 74% of all global fatalities. This includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory conditions, and 2.0 million from diabetes. Consequently, the increasing prevalence of chronic diseases is fueling growth in the pharmaceutical drug delivery market.
Pharmaceutical Drug Delivery Market Segment Performance And Strategic Opportunities
The pharmaceutical drug delivery market covered in this report is segmented –
1) By Route Of Administration: Oral, Ocular, Pulmonary, Nasal, Injectable, Topical, Other Routes
2) By Application: Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Autoimmune Diseases, Other Applications
3) By End-User: Hospitals, Home Care Settings, ASC Or Clinics, Other End Users
Subsegments:
1) By Oral: Tablets, Capsules, Liquids, Powders
2) By Ocular: Eye Drops, Ocular Inserts, Ocular Implants
3) By Pulmonary: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers
4) By Nasal: Nasal Sprays, Nasal Gels, Nasal Powders
5) By Injectable: Intravenous (IV) Injections, Intramuscular (IM) Injections, Subcutaneous (SC) Injections, Biologics And Biosimilars
6) By Topical: Creams, Ointments, Gels, Transdermal Patches
7) By Other Routes: Sublingual, Buccal, Rectal, Intranasal
Pharmaceutical Drug Delivery Market Innovation Trends Driving Future Development
Major players in the pharmaceutical drug delivery market are increasingly turning to strategic partnerships as a way to discover new transport targets and shuttle molecules that can enhance the delivery of medications to the brain. These partnerships involve companies pooling their respective strengths and resources to achieve shared benefits and success. A notable example occurred in September 2023 when Cordance Medical, a medical equipment manufacturer based in the US, entered into a strategic alliance with EXACT Therapeutics to simplify the process of delivering drugs to the brain. This collaboration merges Cordance Medical’s NeuroAccess platform, which is capable of opening the blood-brain barrier (BBB) without surgical intervention, with EXACT Therapeutics’ Acoustic Cluster Therapy (ACT) technology. The partnership is designed to improve the treatment of brain conditions such as tumors and neurodegenerative disorders by facilitating easier access for medicines to reach the brain. EXACT Therapeutics is a clinical-stage biopharmaceutical company headquartered in the UK.
Pharmaceutical Drug Delivery Market Key Players: Which Companies Shape Industry Competition?
Major companies operating in the pharmaceutical drug delivery market are 3M Company., AbbVie Inc., Amgen Inc., AstraZeneca plc, Bayer AG, Becton Dickinson And Company, C. H. Boehringer Sohn AG & Co. KG, Boston Scientific Corporation, Bristol-Myers Squibb Company, Consort Medical plc, Eli Lilly and Company, Emergent Biosolutions Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Johnson & Johnson, Kite Pharma Inc., Merck & Co Inc., Nemera France SAS, Novartis AG, Pfizer Inc, Sanofi S. A., SHL Medical AG, Teva Pharmaceuticals Industries Ltd., West Pharmaceutical Services Inc., Aerogen Pharma Limited, AptarGroup Inc., Biocon Ltd., Catalent Inc., Evonik Industries AG, Inovio Pharmaceuticals Inc., Mylan NV, Sensile Medical Inc., Ypsomed Holding AG
Access The Complete Pharmaceutical Drug Delivery Market Report:
Pharmaceutical Drug Delivery Market Regional Distribution: Which Areas Drive Market Expansion?
North America was the largest region in the pharmaceutical drug delivery market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical drug delivery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
